Ascendis Pharma A/S (ASND)
NASDAQ: ASND · Real-Time Price · USD
136.38
-1.36 (-0.99%)
Dec 20, 2024, 4:00 PM EST - Market closed
Ascendis Pharma Market Cap
Ascendis Pharma has a market cap or net worth of $8.15 billion as of December 20, 2024. Its market cap has increased by 29.92% in one year.
Market Cap
8.15B
Enterprise Value
8.33B
1-Year Change
29.92%
Ranking
Category
Stock Price
$136.38
Market Cap Chart
Since January 28, 2015, Ascendis Pharma's market cap has increased from $448.80M to $8.15B, an increase of 1,715.98%. That is a compound annual growth rate of 34.02%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 20, 2024 | 7.82B | 7.70% |
| Dec 29, 2023 | 7.26B | 4.27% |
| Dec 30, 2022 | 6.96B | -3.83% |
| Dec 31, 2021 | 7.24B | -17.63% |
| Dec 31, 2020 | 8.79B | 32.38% |
| Dec 31, 2019 | 6.64B | 152.21% |
| Dec 31, 2018 | 2.63B | 80.76% |
| Dec 29, 2017 | 1.46B | 185.54% |
| Dec 30, 2016 | 510.20M | 10.84% |
| Dec 31, 2015 | 460.30M | 2.56% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Roivant Sciences | 8.42B |
| Glaukos | 8.31B |
| Teleflex | 8.27B |
| Walgreens Boots Alliance | 8.26B |
| HealthEquity | 8.23B |
| Repligen | 8.09B |
| Chemed | 7.81B |
| The Ensign Group | 7.66B |